Review and download the Traumatic Brain Injury Center of Excellence's 2026 training event calendar. Providers and leaders can learn more about the Acute Concussion Care Pathway, the latest clinical recommendations for TBI management, and other important warfighter brain health topics.

TBICoE's "Mild Traumatic Brain Injury and Post-traumatic Stress Disorder Clinical Pearls," is a supplemental product to the detailed research review. This resource is designed to be a brief and actionable clinical resource for providers treating service members with both mild TBI and PTSD.

Join the Traumatic Brain Injury Center of Excellence for the 2026 Annual Brain Health Symposium, a dynamic, full-day virtual event bringing together leaders in military medicine, neuroscience, and rehabilitation to explore the latest advances in brain health and TBI care. 6 CME/CEs pending

This information paper by the Traumatic Brain Injury Center of Excellence provides a general overview of the current state of the science for using creatine to treat mild TBI and to optimize brain health and performance.

The "Blast Overpressure Provider Support Tool" contains key information about blast overpressure (high and low-level blast), symptoms associated with BOP exposure, and the steps to address BOP exposure—documentation, symptom management, and coding. It also includes details on the occupational specialties and weapon systems that can increase risk of ...

TBICoE developed this fact sheet for service members to learn more about blast overpressure, low-level blast, and high-level blast exposures and what possible effects those exposures can have on their brain health. Service members should be aware of the potential effects of blast exposures, which occupations and heavy weapon systems are associated ...

TBICoE is the Defense Department’s office of responsibility for tracking traumatic brain injury data in the U.S. military. The "DOD TBI Numbers At-A-Glance" provide a high-level overview of TBI's sustained since 2000 and also show the data by severity and service branch.

HBOT is considered an effective treatment for a variety of conditions, but evidence of its effectiveness for the treatment of TBI and post-concussion symptoms remains inconclusive. This information paper summarizes evidence from clinical studies on the use of HBOT for treatment of TBI and post-concussion symptoms.

The long term effects of TBI are unknown, but there is concern that there may be an association with neurodegenerative diseases years after the injury. The intention of this information paper is to summarize the available evidence for or against an association of TBI with three of the more common neurodegenerative diseases.

Establishes DHA's required clinical tools and procedures for management of mild TBI/concussion.